Jonathan Peter Lopez MD

Clinical Pharmacology

Medical Director, Clinical Development

Genentech1 Dna WaySouth San Francisco, CA 94080

Dr. Lopez is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lopez's full profile Already have an account?

Summary

Dr. Jonathan Lopez, based in South San Francisco, CA, specializes in research with a subspecialty in clinical pharmacology. He completed his medical education at the State University of New York Downstate Medical Center College of Medicine and further trained in pediatrics, child neurology, clinical neurophysiology, and epilepsy through residencies and fellowships at Loma Linda University, Stanford University, and the University of Colorado. Dr. Lopez is currently a Medical Director at Genentech, with previous roles as an Assistant Professor at the University at Buffalo and UW Medicine/University of Washington Medical Center, and as a Child Neurologist at Seattle Children's Hospital. His expertise includes child neurology, epilepsy, clinical research, and clinical neurophysiology. He has contributed to a number of published works and led clinical trials focused on multiple sclerosis and Angelman Syndrome.

Education & Training

University of Colorado School of MedicineFellowship, Epilepsy, 2013 - 2014
Stanford Health Care-Sponsored Stanford UniversityFellowship, Clinical Neurophysiology, 2012 - 2013
Stanford Health Care-Sponsored Stanford UniversityResidency, Child Neurology, 2009 - 2012
Loma Linda University Health Education ConsortiumResidency, Pediatrics, 2007 - 2009
State University of New York Downstate Medical Center College of MedicineClass of 2007

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2008 - 2028
NY State Medical License 2021 - 2023
WA State Medical License 2014 - 2021
CO State Medical License 2013 - 2015

Clinical Trials

A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS) Start of enrollment: 2021 Mar 17
ACTIVE_NOT_RECRUITING
PHASE3
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis Start of enrollment: 2020 Oct 26
ACTIVE_NOT_RECRUITING
PHASE3
A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS) Start of enrollment: 2022 May 19
ACTIVE_NOT_RECRUITING
PHASE3

Publications & Presentations

PubMed

16 citations
Phenotypes and Genotypes in Patients with-Related Developmental and Epileptic Encephalopathy.
Xiuhua L Bozarth, Jonathan Lopez, He Fang, Jacqueline Lee-Eng, Zhijun Duan
Genes. 2023-03-31
4 citations
Two Missense CACNA1A Variants in a Single Family with Variable Neurobehavioral, Cerebellar, Epileptic, and Oculomotor Features.
Pin-Yi Ko, Ian A. Glass, Suzanne Crandall, Avery H. Weiss, Michael O. Dorschner
Neuropediatrics. 2021-01-14
8 citations
Awake Mapping of the Auditory Cortex during Tumor Resection in an Aspiring Musical Performer: A Case Report.
David I. Bass, Hillary A. Shurtleff, Molly H. Warner, David Knott, Andrew Poliakov
Pediatric Neurosurgery. 2020-12-01

Books/Book Chapters

Physician's Field Guide to Neuropsychology
Chapter: Neuropsychology’s Contributions to a Pediatric Epilepsy Surgery Team
Page 189 - 208Molly Warner, Hillary Shurtleff, Catherine Amlie-Lefond, Russell Saneto, Edward Novotny, Jonathan Lopez, Sandra Poliachik, Andrew Poliakov, Dennis Shaw, Jeffrey OjemannEditors: Sanders, K.Springer, New York, NYEdition 1,2019
Epilepsy and Brain Tumors
Chapter: Brain-Tumor-Related-Epilepsy in Children
Jonathan LopezElsevier2015